Tobacco Plants Make HIV Antibody

For the first time, a plant-produced antibody gets the green light for clinical trials in the United Kingdom.

By | July 21, 2011

FLICKR, UNIVERSAL POPS

Last month, a monoclonal antibody produced in the leaves of tobacco plants entered phase I clinical trials in the United Kingdom. The antibody, known as P2G12, recognizes an HIV surface protein and is expected to help stop the transmission of the virus, although it has never been tested in humans. The phase I trial, underway at the University of Surrey, will test the safety of vaginally applying the antibody to 11 healthy women.

This is the first plant-produced antibody to be cleared for clinical trials by the Medicines and Healthcare Products Agency (the UK equivalent of the US Food and Drug Administration). Producing the antibody using tobacco plants grown in a greenhouse in Germany is 10 to 100 times cheaper than using conventional methods employing bacteria or mammalian cells, Smart Planet reports. “Monoclonal antibodies can be made in plants to the same quality as those made using existing conventional production systems," Professor Julian Ma from St George's University, London and joint co-ordinator of the project, told The Guardian. “That is something many people did not believe could be achieved.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Iucidium

Iucidium

Posts: 1

July 22, 2011

Insert Bill Clinton/Monica Lewinski joke here.

Avatar of:

Posts: 0

July 22, 2011

Insert Bill Clinton/Monica Lewinski joke here.

Avatar of:

Posts: 0

July 22, 2011

Insert Bill Clinton/Monica Lewinski joke here.

Avatar of: Krithi

Anonymous

July 23, 2011

very intresting news

Avatar of:

Posts: 0

July 23, 2011

very intresting news

Avatar of:

Posts: 0

July 23, 2011

very intresting news

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS